Soliton with ticker code (SOLY) now have 3 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 22 and 12 and has a mean target at 16. Now with the previous closing price of 8.37 this would indicate that there is a potential upside of 91.2%. There is a 50 day moving average of 8.4 while the 200 day moving average is 8.22. The company has a market capitalisation of $177m. You can visit the company’s website by visiting: http://www.soliton.com
Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.